BX
Baudax Bio, Inc.
BXRXQ · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $4.36K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.00x
P/FCF N/A
P/FFO N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
0 /100
Weak FCF margin 2,191.73%
Op. margin 4,476.99%
Gross margin 452.33%
Quality
59 /100
Average ROA 586.08%
Asset turnover 0.13x
ROIC 974.83%
Debt
70 /100
Low Net debt/EBITDA -0.06x
Current ratio 0.30x
Int. coverage N/A
Stability
32 /100
Unstable EPS volatility 55.97%
Profitable years 0
Beta -24.30x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BXRXQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gerri Henwood
Employees
9
Headquarters
Malvern
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report